SCHEMBL618894

SCHEMBL618894

CCCCC[Si](O)(CCCCC)CCCCC

nearest known ligand 0.44

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
TSHR P16473 3/20 0.44
THRB P10828 1/20 0.44
SMN1; SMN2 Q16637 1/20 0.42
LMNA P02545 3/20 0.40
ALDH1A1 P00352 2/20 0.40
HSD17B10 Q99714 1/20 0.40
MEN1 O00255 1/20 0.40
KMT2A Q03164 1/20 0.40
CES2 O00748 4/20 0.36
CES1 P23141 4/20 0.36
EPHX1 P07099 4/20 0.36
SLC22A1 O15245 2/20 0.35
SLC22A2 O15244 1/20 0.35
AKR1B1 P15121 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL618296 0.97 TSHR (0.50) TSHRTHRBSMN1; SMN2LMNAALDH1A1
SCHEMBL2920003 0.97 TSHR (0.50) TSHRTHRBSMN1; SMN2LMNAALDH1A1
SCHEMBL2922266 0.97 TSHR (0.50) TSHRTHRBSMN1; SMN2LMNAALDH1A1
SCHEMBL2917826 0.97 TSHR (0.50) TSHRTHRBSMN1; SMN2LMNAALDH1A1
SCHEMBL2920815 0.97 TSHR (0.50) TSHRTHRBSMN1; SMN2LMNAALDH1A1
SCHEMBL2918415 0.97 TSHR (0.50) TSHRTHRBSMN1; SMN2LMNAALDH1A1
SCHEMBL17090784 0.97 TSHR (0.50) TSHRTHRBSMN1; SMN2LMNAALDH1A1
SCHEMBL10984369 0.97 TSHR (0.50) TSHRTHRBSMN1; SMN2LMNAALDH1A1
SCHEMBL2917797 0.97 TSHR (0.50) TSHRTHRBSMN1; SMN2LMNAALDH1A1
SCHEMBL17090836 0.97 TSHR (0.50) TSHRTHRBSMN1; SMN2LMNAALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 180 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20020010301-A1 Process for producing fluorosilicon polymers GENERAL ELECTRIC CO. 2002-01-24 US claimed
US-20250313752-A1 METHOD FOR PRODUCING AQUEOUS SOLUTION OF PURIFIED AMINOSILANOL COMPOUND AND AMINOSILOXANE COMPOUND, AND COMPOSITION FOR ETCHING SHIN-ETSU CHEMICAL CO., LTD. (JP) 2025-10-09 US disclosed
EP-4527841-A1 METHOD FOR PRODUCING AQUEOUS SOLUTION OF PURIFIED AMINOSILANOL COMPOUND AND AMINOSILOXANE COMPOUND, AND COMPOSITION FOR ETCHING SHIN-ETSU CHEMICAL CO., LTD. (JP) 2025-03-26 EP disclosed
EP-3904360-B1 NOVEL TETRAARYLBORATE COMPOUND, CATALYST COMPOSITION COMPRISING SAME, AND METHOD FOR PREPARING ETHYLENE HOMOPOLYMERS OR COPOLYMERS OF ETHYLENE AND ALPHA-OLEFIN BY USING SAME SABIC SK NEXLENE COMPANY PTE LTD (SG) 2024-07-03 EP disclosed
CN-113677686-B Novel tetraarylborate compounds, catalyst compositions comprising the same, and process for preparing ethylene homopolymers or copolymers of ethylene and alpha-olefins by using the same 沙特基础工业爱思开NEXLENE私人有限公司 2024-06-11 CN disclosed
WO-2023223803-A1 METHOD FOR PRODUCING AQUEOUS SOLUTION OF PURIFIED AMINOSILANOL COMPOUND AND AMINOSILOXANE COMPOUND, AND COMPOSITION FOR ETCHING 信越化学工業株式会社 2023-11-23 WO disclosed
US-11795064-B2 Polymetalloxane, method for producing same, composition thereof, cured film and method for producing same, and members and electronic components provided with same TORAY INDUSTRIES, INC. (JP) 2023-10-24 US disclosed
EP-3689891-B1 COBALT COMPLEX, PRODUCTION METHOD THEREFOR, AND CATALYST FOR HYDROSILYLATION REACTION UNIV KYUSHU NAT UNIV CORP (JP) 2023-03-01 EP disclosed
CN-113677686-A Novel tetraarylborate compound, catalyst composition comprising the same, and method for preparing ethylene homopolymer or copolymer of ethylene and alpha-olefin by using the same 沙特基础工业爱思开NEXLENE私人有限公司 2021-11-19 CN disclosed
EP-3904360-A1 NOVEL TETRAARYLBORATE COMPOUND, CATALYST COMPOSITION COMPRISING SAME, AND METHOD FOR PREPARING ETHYLENE HOMOPOLYMERS OR COPOLYMERS OF ETHYLENE AND ALPHA-OLEFIN BY USING SAME SABIC SK Nexlene Company Pte. Ltd. (SG) 2021-11-03 EP disclosed
US-5017694-A With silanol-type compounds RHONE-POULENC, INC. (US) 1991-05-21 US disclosed
US-5017695-A With cerium ammonium nitrate and silanol-type compound RHONE-POULENC, INC. (US) 1991-05-21 US disclosed
EP-0425976-A2 Cycloalkylidene dye-stuffs BASF Aktiengesellschaft (DE) 1991-05-08 EP disclosed
EP-0411150-A1 INDOLE DERIVATIVES, PREPARATION THEREOF, AND DRUG FOR PREVENTING AND TREATING NEPHRITIS CONTAINING SAME OTSUKA PHARMACEUTICAL CO., LTD. (JP) 1991-02-06 EP disclosed
EP-0324671-A2 Alkoxy-type derivatives of trivalent metals of group 3b, and their preparation RHONE-POULENC CHIMIE (FR) 1989-07-19 EP disclosed
EP-0319383-A2 Process for the fabrication of cerium hydrocarbonsilyloxides by transetherification of cerium alkoxides RHONE-POULENC CHIMIE (FR) 1989-06-07 EP disclosed
EP-0319384-A2 Cerium hydrocarbonsilyloxydes and process for their manufacture RHONE-POULENC CHIMIE (FR) 1989-06-07 EP disclosed
EP-0123060-B1 ULTRAPURE CRYSTALLINE SILICA POLYMORPHS AND PROCESS FOR THE PREPARATION THEREOF E.I. DU PONT DE NEMOURS AND COMPANY (US) 1987-11-04 EP disclosed
EP-0123060-A1 Ultrapure crystalline silica polymorphs and process for the preparation thereof E.I. DU PONT DE NEMOURS AND COMPANY (US) 1984-10-31 EP disclosed
US-3972982-A EXTRACTION WITH A SILANE AND A HYDROCARBYL AMINE MONSANTO COMPANY (US) 1976-08-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11795064-B2 Polymetalloxane, method for producing same, composition thereof, cured film and method for producing same, and members and electronic components provided with same ASH2L, SETDB1, BMI1 TSHR 4422/4885THRB 4529/4885SMN1; SMN2 1535/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.